FAM

Fred Alger Management Portfolio holdings

AUM $22.8B
1-Year Est. Return 65.86%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+65.86%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$22.8B
AUM Growth
-$2.73B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
522
New
Increased
Reduced
Closed

Top Buys

1
+$198M
2
+$166M
3
+$148M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$96.2M
5
ARWR icon
Arrowhead Research
ARWR
+$95.6M

Top Sells

1
+$241M
2
+$218M
3
+$183M
4
VST icon
Vistra
VST
+$130M
5
META icon
Meta Platforms (Facebook)
META
+$121M

Sector Composition

1 Technology 38.97%
2 Communication Services 18.14%
3 Consumer Discretionary 12.78%
4 Healthcare 10.98%
5 Industrials 10.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GMAB icon
476
Genmab
GMAB
$15.4B
– –
-130,470
GNTX icon
477
Gentex
GNTX
$5.25B
– –
-13,118
HURN icon
478
Huron Consulting
HURN
$1.78B
– –
-1,520
NTNX icon
479
Nutanix
NTNX
$14.5B
– –
-6,358
OGN icon
480
Organon & Co
OGN
$3.51B
– –
-41,502
OLMA icon
481
Olema Pharmaceuticals
OLMA
$901M
– –
-64,484
OPCH icon
482
Option Care Health
OPCH
$3.22B
– –
-6,345
PCOR icon
483
Procore
PCOR
$7.33B
– –
-64,445
PCTY icon
484
Paylocity
PCTY
$6.08B
– –
-33,714
PODD icon
485
Insulet
PODD
$10.6B
– –
-11,077
QQQ icon
486
Invesco QQQ Trust
QQQ
$469B
– –
0
RCUS icon
487
Arcus Biosciences
RCUS
$2.92B
– –
-44,758
ROP icon
488
Roper Technologies
ROP
$33.5B
– –
-4,523
RYTM icon
489
Rhythm Pharmaceuticals
RYTM
$5.93B
– –
-9,301
SWKS icon
490
Skyworks Solutions
SWKS
$11.1B
– –
-3,691
DJT icon
491
Trump Media & Technology Group
DJT
$2.29B
– –
0
EXE
492
Expand Energy Corp
EXE
$22B
– –
-26,538
BABA icon
493
Alibaba
BABA
$290B
– –
-134,569
BGC icon
494
BGC Group
BGC
$5.2B
– –
-10,641
BILL icon
495
BILL Holdings
BILL
$3.58B
– –
-5,829
BLDR icon
496
Builders FirstSource
BLDR
$7.92B
– –
-375,723
BLKB icon
497
Blackbaud
BLKB
$1.3B
– –
-37,053
COMP icon
498
Compass
COMP
$5.76B
– –
-1,270,563
CPRI icon
499
Capri Holdings
CPRI
$2.17B
– –
-54,017
CRVS icon
500
Corvus Pharmaceuticals
CRVS
$935M
– –
-144,381
17 18 19
20
21